Kineta, Inc. (KA) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Seattle, WA, 미국. 현재 CEO는 Craig W. Philips.
KA 을(를) 보유 IPO 날짜 2016-02-11, 11 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $7.05M.
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
